Element Biosciences develops genomic sequencing and multiomics technologies used in biological research, drug discovery, and diagnostic applications. Its product portfolio includes sequencing platforms such as AVITI, AVITI24, and VITARI, which support the analysis of DNA, RNA, proteins, and cellular morphology across a range of research workflows. The company’s proprietary Avidite Base Chemistry technology is designed to improve sequencing accuracy and efficiency through innovations in surface chemistry, amplification methods, and data analysis. Element Biosciences also provides integrated multiomics capabilities that enable researchers to generate and combine multiple types of biological data from a single sample. Its technologies are used in fields such as genomics, cancer research, pharmaceutical development, and agricultural biotechnology.